title: Post marketing surveillance of new drugs. Patient safety in the hands of GPs.
abstract: Is the post market surveillance--the monitoring for safety and tolerability of new drugs--reliable? Will it become compulsory? How does it compare with current detection methods? How reliable are promotional claims drawn from it? This review is a guide to the present, and the implications for the future for general practice.
authors.forename: J E
authors.initials: JE
authors.lastname: Marley
mesh_terms: D001315:Australia; D003257:Consumer Product Safety; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors